Purple Sweet Potato Pigments Slowed Gut Aging in Mice by Rewiring the Microbiome

Aging quietly dismantles the gut. The intestinal lining thins, stem cells that replenish it slow down, and the microbial community that supports them shifts toward less helpful species. A new study published in Food & Function by Gu Y and colleagues suggests that anthocyanins extracted from purple sweet potatoes (PSPAs) may interrupt that cascade, at least in naturally aged mice, through a mechanism the researchers call the "microbiota-autophagy-stem cell axis."

PSPAs Reversed Multiple Aging Hallmarks in the Gut

The study treated naturally aged mice with purple sweet potato anthocyanin extracts and measured outcomes across the whole gut-aging picture. The results were broad: PSPAs restored tight junction protein expression, which keeps the gut lining sealed; improved epithelial architecture; and enhanced the proliferative and differentiation capacity of intestinal stem cells (ISCs), the cells responsible for renewing the intestinal lining every few days. Beyond the gut itself, supplemented animals also showed improvements in motor coordination, hepatic lipid dysregulation, and insulin resistance, as well as reduced markers of cellular senescence. Notably, these effects on barrier integrity appeared to be independent of inflammation resolution, suggesting the mechanism runs through a different channel than the anti-inflammatory pathways often credited to dietary polyphenols.

Why an Aging Gut Barrier Matters Far Beyond Digestion

The stakes here go well past indigestion. As research on aging gut barriers has shown, a dysfunctional intestinal lining allows unwanted substances to leak into surrounding tissue, fueling the low-grade chronic inflammation that underlies many age-related diseases. Broader reviews link gut barrier dysfunction in humans to conditions ranging from celiac disease and inflammatory bowel disease to type 2 diabetes, chronic heart failure, and obesity. The intestinal stem cell population is central to this story: when ISCs slow down, the epithelium cannot renew itself fast enough to maintain a robust barrier. Restoring their function is therefore an attractive target for gut-centered aging interventions.

How the Microbiota-Autophagy-Stem Cell Axis Works

The mechanistic core of the paper involves three linked steps. First, PSPAs remodeled the aging-associated gut microbiota composition and functions, confirmed by metagenomic profiling. This is consistent with earlier work showing that purple sweet potato anthocyanin extract restores gut microbiota balance in obese mice, promoting beneficial genera including Akkermansia, Bifidobacterium, and Lactobacillus. Second, to establish that microbial changes were actually driving ISC rejuvenation rather than merely accompanying it, the team performed fecal microbiota transplantation (FMT): transferring microbiota from PSPA-treated aged mice into untreated recipients reproduced the ISC benefits, confirming a causal link. Third, luminal content-organoid assays, in which intestinal organoids were exposed to microbial metabolites from treated animals, confirmed that soluble products of the remodeled microbiota were sufficient to rejuvenate ISC activity in culture. Integrative metabolomics tied these changes to autophagy-related processes and altered short-chain fatty acid (SCFA) profiles; transcriptomic analysis pointed to PI3K-AKT signaling as the dominant downstream pathway. Prior work on purple sweet potato anthocyanins in colitis models also found microbiota remodeling, with shifts away from Proteobacteria and toward Firmicutes and Bacteroidetes, suggesting microbiome modulation may be a consistent feature of this compound class.

Key Limitations Before This Translates to People

This is early-stage, investigational research, and several gaps need bridging before the findings say anything definitive about human nutrition. The entire study was conducted in mice; rodent gut physiology and aging trajectories differ meaningfully from human ones, and aged mouse models, while valuable for uncovering mechanisms, do not guarantee clinical translation. The specific dose, formulation, and bioavailability of PSPAs in humans remain untested. Reviewers of the broader anthocyanin literature have repeatedly noted that most mechanistic findings come from animal or cell models and that clinical trials are scarce. The study also did not tease apart which individual anthocyanin species within the extract are responsible for the observed effects, leaving the active pharmacology somewhat unresolved.

What Needs to Happen Next

The microbiota-autophagy-stem cell axis the authors describe is a precise and testable framework, which is arguably the most useful output of the paper at this stage. Future work will need to identify which microbial taxa are most important to the remodeling effect, determine which SCFA or other metabolite signals activate autophagy in ISCs, and run dose-ranging and pharmacokinetic studies in humans. Whether the PI3K-AKT pathway represents a druggable node or simply a readout of upstream metabolic changes is another open question. If the mechanistic chain holds in human tissue, the findings would support a rationale for polyphenol-based dietary strategies aimed at maintaining gut integrity with age, a target with few existing pharmacological options. For now, the study offers a well-characterized molecular story grounded in solid animal-model work, and a clear map for the clinical research that would need to follow.

Evidence rating

INVESTIGATIONAL — 73/100

Caveats:

• This study was conducted entirely in mice and intestinal organoids — results have not been tested in humans.
• Funding source was not disclosed by the authors.
• Single study with no independent replication to date.

Preclinical study conducted in naturally aged mice and intestinal organoids. Demonstrates a mechanistic causal chain via fecal microbiota transplantation and multi-omics profiling, but findings are limited to an animal model with no human cohort data. Not yet replicated in an independent study.

References

1. Yanpei Gu, Lulu Li, Haichao Zhang, et al. (2026). Dietary purple sweet potato anthocyanin extracts attenuate intestinal barrier decline in naturally aged mice via the microbiota–autophagy–stem cell axis. Food & Function. https://doi.org/10.1039/d6fo00039h
2. Aging of the Intestinal Barrier as a Driving Cause of Chronic Inflammation. frontiersin.org. https://www.frontiersin.org/articles/10.3389/fmed.2022.846460/full
3. Claudio Nicoletti (2015). Age-associated changes of the intestinal epithelial barrier: local and systemic implications. Expert Review of Gastroenterology & Hepatology. https://doi.org/10.1586/17474124.2015.1092872
4. Dong Liu, Yanglin Ji, Kexin Wang, et al. (2022). Purple sweet potato anthocyanin extract regulates redox state related to gut microbiota homeostasis in obese mice. Journal of Food Science. https://doi.org/10.1111/1750-3841.16130
5. Jing Chen, Fei Jiang, Nana Xu, et al. (2024). Anthocyanin Extracted from Purple Sweet Potato Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice by Suppressing Pyroptosis and Altering Intestinal Flora Structure. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2023.k.0247
6. Jae Hyun Shin, Sean W. Pawlowski, Cirle A. Warren (2021). Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response. Gut Microbes. https://doi.org/10.1080/19490976.2021.1966255
7. Anthocyanins-gut microbiota-health axis: A review. tandfonline.com. https://www.tandfonline.com/doi/full/10.1080/10408398.2023.2185746